Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 02-2026 | 11-2025 | 08-2025 | 05-2025 | 02-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,837 | -28,147 | -5,540 | 3,745 | 9,701 |
| Depreciation Amortization | 13 | 9 | 4 | 425 | 362 |
| Other Working Capital | 17,770 | 20,676 | 2,907 | -16,172 | -15,803 |
| Other Operating Activity | 2,735 | 662 | 179 | 3,237 | 2,638 |
| Operating Cash Flow | $-12,319 | $-6,800 | $-2,450 | $-8,765 | $-3,102 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,339 | 21 | 21 | 11,564 | 10,398 |
| Other Financing Activity | 732 | -142 | -142 | -710 | -710 |
| Financing Cash Flow | $16,071 | $-121 | $-121 | $10,854 | $9,688 |
| Beginning Cash Position | 11,903 | 11,903 | 11,903 | 9,814 | 9,814 |
| End Cash Position | 15,655 | 4,982 | 9,332 | 11,903 | 16,400 |
| Net Cash Flow | $3,752 | $-6,921 | $-2,571 | $2,089 | $6,586 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,319 | -6,800 | -2,450 | -8,765 | -3,102 |
| Free Cash Flow | -12,319 | -6,800 | -2,450 | -8,765 | -3,102 |